Cover Image
市場調查報告書

醫療相關感染(HAI)管理的全球市場:消毒、殺菌、治療、檢驗

Hospital-Acquired Infection (HAI) Control Market (Disinfection, Sterilization, Treatment, Testing)

出版商 Kalorama Information 商品編碼 304515
出版日期 內容資訊 英文 229 Pages
訂單完成後即時交付
價格
Back to Top
醫療相關感染(HAI)管理的全球市場:消毒、殺菌、治療、檢驗 Hospital-Acquired Infection (HAI) Control Market (Disinfection, Sterilization, Treatment, Testing)
出版日期: 2016年01月25日 內容資訊: 英文 229 Pages
簡介

所謂在醫療設施內的感染疾病管理,一般的情況是指防止外部侵入的感染疾病侵害患者、職員。另一方面,對醫療行為途中感染、發病的感染疾病 - 醫療相關感染(HAI)或院內感染的 - 的擔憂、關心高漲。HAI是術後從疤痕部產生,有可能發生與疾病無關的併發症。

本報告提供全球及美國的醫療相關感染(HAI)- 院內感染和其他治療、醫療行為相關的感染疾病 - 的管理市場相關調查,主要的感染疾病的預防方法和檢驗手法,治療手段概要與趨勢,各地區市場分析,今後的市場進入機會,主要企業企業簡介的資訊彙整,為您概述為以下內容。

摘要整理

簡介與產業趨勢

  • 概要
  • 病原體概要
  • 全球人口統計
  • 醫院的感染風險評估
  • 經濟趨勢
  • 降低院內感染的政策
  • 醫藥品廠商和市場行銷趨勢

預防感染

  • 概要
    • 傳染方法
    • 高風險設施或部門
    • 技術概要
    • 殺菌和消毒
    • 設備與解決方案
      • 蒸氣殺菌
      • 科學性殺菌
      • 殺菌劑
      • 中度的消毒
      • 放射線殺菌
      • 殺菌和消毒的檢驗系統
  • 市場概要
    • 各地區市場
    • 競爭分析

感染檢驗

  • 概要
    • 藥物抗性/敏銳度檢驗
    • 遺傳基因型決策法
  • 特別嚴重的醫療感染檢驗
    • 鮑氏靜止桿菌
    • 困難腸梭菌
    • 院內肺炎
    • 綠色膿菌
    • 黃色葡萄球菌
    • 結核
    • 尿道感染
    • 萬古霉素抗藥性腸球菌
    • 人工呼吸器相關肺炎
  • 新的發展
  • 市場概要
  • 市場規模與預測
  • 競爭分析

感染治療

  • 概要
    • 抗菌治療的原則
    • 感染生物
    • 抗生素敏銳度檢驗
    • 感染部位
    • 宿主防禦與內臟器官功能
    • 抗生素的藥物動力學
    • 治療的監測
  • 抗菌產品的分類
  • 治療指南
  • 主要產品
  • 新的發展
  • 市場概要
  • 市場規模與預測
  • 競爭分析

醫療相關感染管理的市場機會

  • 市場討論事項
  • 市場概要
  • 各地區的市場:已開發國家、新興國家市場分析

企業簡介

  • 簡介
  • Advanced Sterilization Products
    • 企業的業績
  • Becton, Dickinson and Company
  • Belimed
  • bioMerieux
  • Cantel
  • Cepheid
  • Getinge Group
  • Merck & Co
  • Nordion
  • Pfizer
  • Roche
  • 櫻花精密機械
  • Steris
  • Tso3

主要供應商的一覽

圖表一覽

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: KLI5854190

Infection control in health care facilities deals largely with protecting building occupants from patients with communicable infectious diseases. Infections, which may result from activities and procedures taking place within the facility, have become a cause for great concern. Infection that is acquired during the course of health care is known as a nosocomial, or hospital acquired, infection. The infection may occur in a postoperative wound or as a complication unrelated to the disease or condition.

This Kalorama Information report, Hospital-Acquired Infections takes a solid look at

    Hospital-Acquired Infection Statistics Device Sterilization Market Hospital Area Disinfection Market HAI Testing Market Treatment Market Market Segmentation by Healthcare Location: Hospital, Nursing Home, Other Market Segmentation by Geographic Location: US, EU, Asia, Other

There are several challenges facing the healthcare industry which contribute to the problem of healthcare-acquired infections. These are outlined below:

  • Increasing health expenditures have promoted the use of reusable medical equipment and supplies. This has inadvertently added increased risk over disposable products.
  • The aging population is increasing the need for improved HAI prevention measures. These are among the most vulnerable patients.
  • Increasing disease incidence and comorbid conditions generates a growing at-risk population for HAIs.
  • Compliance among medical staff in HAI prevention measures is still a concern, despite the growing awareness and education efforts.
  • Reducing HAIs to at or below the national average is acceptable. This may slow aggressiveness once this goal is realized.

Market analysis in this report considers primarily the epidemiological considerations and the size patient groups both in the United States and globally, where available. We have accumulated the most recent data available, understanding that virtually no organization does extensive studies on these applications on a regular basis. Many studies are highly localized and may only apply to a community, state or country (more often countries that are not a part of the major markets for nosocomial diagnostic and therapeutic products). In many instances, we have had to draw from broader epidemiologic data, that is, on data that reach outside of the hospital and primary care environment in order to construct a picture of the infection prevention, testing and treatment needs.

ISSUES AND TRENDS AFFECTING MARKET

The area of hospital infections represents a difficult market landscape with several key trends affecting a product manufacturer's ability to successfully operate in the market, including:

  • Development of fast testing systems
  • Growing drug resistance
  • Attention to special population issues
  • Demographics and epidemiology
  • New government guidelines and requirements for preventing infection

Special considerations must be addressed while evaluating the potential market opportunities and restraints, including:

  • Nosocomial infections are a fact of life-while the incidence of any specific nosocomial infection may decline, it will be compensated for by the rise of a new infection or an increase in the incidence of another, existing, nosocomial infection.
  • The incidence of drug-resistant nosocomial infections is on the rise and can be expected to accelerate in the near future.
  • Multi-drug- or extensive-drug-resistance will further limit the effectiveness of existing therapeutics, and require improved detection of disease and treatment plans.
  • The hospital setting is badly in need of new, rapid testing procedures to define a pathogen's susceptibility to antibacterial treatment.
  • Other inpatient facilities, such as long-term care, are increasingly demanding products to reduce the risk of infection.
  • The hospital setting and the public health environment as a whole are in need of new antimicrobial therapeutic agents to combat infection, however the pipeline for these therapies is limited-calling for a need in prevention and detection.
  • Focus on alliances and partnerships to expand development programs.

LEADING COMPETITORS

The majority of competitive participation for hospital infection control and is in the United States and Europe. However, competition is steadily escalating in the United States and Europe, which is encouraging more participation in other areas such as Asia and Latin America. Companies included in this chapter are:

  • Advanced Sterilization Products
  • Becton Dickinson
  • Belimed AG
  • bioMerieux
  • Cantel
  • Cepheid
  • Getinge
  • Merck & Co.
  • Nordion
  • Pfizer
  • Roche
  • Sakura Seiki
  • Steris
  • TSO3

In looking at infections in the health environment, we consider the diagnostic and therapeutic technologies that are currently available and attempt to project trends for preventing, detecting and treating these infections. To some extent, we are limited by the activity of the industries associated with the activities mentioned above for these infections. For the most part, these activities are limited and the advanced technologies seen in other areas of medical application are not necessarily present in terms of microbiology.

RESEARCH METHODOLOGY

The analysis presented in this report is based on data from a combination of company, government, industry, institutional and private sources. It includes information from extensive literature reviews and discussions with experts in the field, including microbiologists, pathologists, hospital authorities, reimbursement specialists, research scientists, business development managers and marketing managers.

Table of Contents

EXECUTIVE SUMMARY

  • Overview
  • The Nosocomial Infection
  • Market Scope
  • Research Methodology
  • Industry Challenges
  • Total Size and Growth of the Market
  • Issues and Trends Affecting Market
  • Leading Competitors

INTRODUCTION AND INDUSTRY TRENDS

  • Overview
  • Introduction to Pathogens
  • Classification of Antibacterial Organisms
  • Common Hospital (nosocomial) Infections
  • Description of Infections
  • Acinetobacter Baumannii
  • Clostridium Difficile
  • Gastroenteritis
  • Hospital-Acquired Pneumonia (HAP)
  • Pseudomonas Aeruginosa
  • Staphylococcus Aureus/Methicillin-Resistant Staphylococcus Aureus
  • Stenotrophomonas Maltophilia
  • Tuberculosis
  • Urinary Tract Infections
  • Vancomycin-Resistant Enterococcus
  • Ventilator-Associated Pneumonia (VAP)
  • Patient Risk Factors
  • General Populations at Risk for Infection
  • World Demographics
  • Assessing the Problem: Nosocomial Infection Statistics
  • Infection Risk Assessments by Hospital Department
  • Burn Units
  • Intensive Care Units
  • Emergency Departments
  • Hospital Length of Stay
  • Increased Hospital Length of Stay for HAIs
  • Extended Stay Environments
  • International Trends in Nursing Facilities
  • Economic Trends
  • Comparison between Healthcare Spending and Real Health Outcomes
  • U.S. Government's National Plan to Prevent Healthcare Associated Infections (HAIs)43
  • Steering Committee
  • Affordable Care Act (ACA) Funding
  • Government Funding for HAI Prevention Infrastructure Activities
  • The Department of Health and Human Services: 2016 Budget Highlights
  • National Healthcare Safety Network
  • Hospital infection Surveillance Process
  • Screening Hospitalized Patients
  • Pharmaceutical Manufacturer and Marketer Trends
  • Trends in Partnerships and Alliances
  • Developers Trends

INFECTION PREVENTION

  • Overview
  • Methods of Transmission
  • Airborne
  • Contact
  • Droplet
  • Vehicle
  • High-Risk Facilities or Departments
  • Technology Overview
  • Potential Use of Copper for Reducing Infections
  • Wide Area Disinfection Methods
  • Software for Infection Detection and Control
  • Antiseptic-Coated Catheters
  • UV-C Reflective Coatings
  • Specialized Disinfection/Sterilization Systems
  • Sterilization vs. Disinfection
  • Sterilization
  • Disinfection
  • Equipment and Solutions
  • Heat/Steam Sterilization
  • Product Examples
  • Chemical Sterilization
  • Sterilants
  • Product Examples
  • Mid-Level Disinfectants
  • Suppliers
  • Radiation Sterilization
  • Product Examples
  • Sterilization and Disinfection Verification Systems
  • Market Overview
  • Hospital infection Prevention Market by Geographical Region
  • Competitive Analysis

INFECTION TESTING

  • Overview
  • Drug-Resistance/Susceptibility Testing
  • Genotypic Methods
  • DNA Sequencing
  • Solid-phase Hybridization Techniques
  • Microarrays
  • Real-time Polymerase Chain Reaction Techniques
  • Phenotypic Methods
  • Phage-based Assays
  • Colorimetric Methods
  • The Nitrate Reductase Assay
  • Specific Serious Hospital infection Testing
  • Acinetobacter Baumannii
  • Clostridium Difficile
  • Product Examples
  • Hospital-Acquired Pneumonia
  • Pseudomonas Aeruginosa
  • Staphylococcus Aureus
  • Methicillin-resistant Staphylococcus Aureus (MRSA)
  • Vancomycin-Intermediate/Resistant Staphylococcus Aureus (VISA/VRSA)
  • Product Examples
  • Tuberculosis
  • Product Examples
  • Urinary Tract Infections
  • Vancomycin-resistant Enterococcus
  • Ventilator-Associated Pneumonia
  • New Developments
  • Market Overview
  • Total Market Size and Forecast
  • Hospital infection Testing Market by Geographical Region
  • Competitive Analysis

INFECTION TREATMENT

  • Overview
  • Principles of Anti-bacterial Therapy
  • Infecting Organism
  • Antibiotic Sensitivity Testing
  • Site of Infection
  • Host Defenses and Organ Function
  • Antibiotic Pharmacokinetics
  • Monitoring Therapy
  • Classifications of Antibacterial Products
  • Carbapenems
  • Cephalosporins
  • Macrolides
  • Penicillins
  • Quinolones
  • Sulfonamides
  • Tetracyclines
  • Infections and Drug Resistance
  • Easing Approvals of Antibiotics
  • Causes of Drug Resistance
  • Antibiotic Abuse
  • Antibiotic Use in Agriculture
  • Drug Resistance in Select Populations
  • Children
  • The Elderly
  • Compromised Individuals
  • Measures for Reducing Resistance
  • Testing for the Selection of Anti-bacterial Therapy
  • Monitoring Therapy
  • Treatment Guidelines
  • Clostridium Difficile
  • Gastroenteritis
  • Hospital-Acquired Pneumonia
  • Ventilator-associated Pneumonia
  • Pseudomonas Aeruginosa
  • Staphylococcus Aureus
  • Stenotrophomonas maltophilia
  • Tuberculosis
  • Urinary Tract Infections
  • Leading Products
  • New Developments
  • Development Incentives
  • Total Market Size and Forecast
  • Hospital infection Treatment Market by Geographical Region
  • Competitive Analysis

MARKET OPPORTUNITIES FOR HOSPITAL INFECTION CONTROL

  • Market Considerations
  • Market Overview
  • Healthcare-Acquired Infection Distribution by Setting
  • The Global Market for Hospital infection Control Estimated Market Share by Facility Setting, 2015
  • The Global Market for Hospital infection Control Estimated Market Share by Hospital Department,2015
  • Hospital infection Control Market by Geographical Region
  • Developed and Emerging Market Analysis

COMPANY PROFILES

  • Introduction
  • Advanced Sterilization Products
  • Company Performance
  • Becton, Dickinson and Company
  • Company Performance
  • Belimed
  • Company Performance
  • bioMerieux
  • Company Performance
  • Cantel
  • Company Performance
  • Cepheid
  • Company Performance
  • Getinge Group
  • Company Performance
  • Merck & Co
  • Company Performance
  • Nordion
  • Company Performance
  • Pfizer
  • Company Performance
  • Roche
  • Company Performance
  • Sakura Seiki
  • Steris
  • Company Performance
  • Tso3
  • Company Performance

LIST OF MAJOR PROVIDERS

LIST OF EXHIBITS

EXECUTIVE SUMMARY

  • Table 1-1: Frequency of the Most Common Nosocomial Infections
  • Table 1-2: Growth Drivers and Inhibitors
  • Table 1-3: The Global Market for Hospital infection Control 2010-2020
  • Figure 1-1: The Global Market for Hospital infection Control 2010-2020

INTRODUCTION AND INDUSTRY TRENDS

  • Table 2-1: Global Population at Risk for Serious Bacterial Infections, Secondary to Chronic Diseases by Selected Geographical Region(US, EU, Asia, ROW)
  • Figure 2-1: Global Population at Risk for Serious Bacterial Infections, Secondary to Chronic Diseases by Selected Geographical Region(US, EU, Asia, ROW)
  • Table 2-2: Global Population Change, 2005 - 2050
  • Figure 2-2: Global Population Change, 2005-2050
  • Table 2-3: World Population by Selected Geographical Region(US, EU, Asia, ROW), 2010 - 205030
  • Figure 2-3: World Population by Selected Geographical Region(US, EU, Asia, ROW), 2010-205030
  • Figure 2-4: U.S. Hospital Admissions and Percent of Hospital-acquired Infections (HAIs)by Type - (MRSA, C.diff, Other)
  • Figure 2-5: European Union Hospital Admissions and Percent of Hospital-acquired Infections(HAIs) by Type (Bloodstream, Upper&Lower RTI, MRSA, Other)
  • Figure 2-6: Average International Length of Stay (LOS), by Country 2015 Estimates
  • Figure 2-7: Number of Nursing Homes (United States), 2000-2012
  • Figure 2-8: Total Healthcare Expenditures as a Percent of GDP by Country 2010 and 2014
  • Table 2-4: U.S. States ACA HAI Prevention Infrastructure Funding Awards, 2013-2015
  • Table 2-4 (continued): U.S. States ACA HAI Prevention Infrastructure Funding Awards, 2013-2015
  • Table 2-5: U.S. Hospital Acquired Infection Standardized Infection Ratio (SIR) 2010, 2011, 2012 and 2013
  • Figure 2-9: U.S. Hospital Acquired Infection Standardized Infection Ratio (SIR) 2010, 2011, 2012 and 2013

INFECTION PREVENTION

  • Table 3-1: Summary of Advantages and Disadvantages of Chemical Agents Used as Chemical Sterilants1 or as High-Level Disinfectants
  • Table 3-1 (continued): Summary of Advantages and Disadvantages of Chemical Agents Used as Chemical Sterilants1 or as High-Level Disinfectants
  • Table 3-2: Comparison of the Characteristics of Selected Chemicals Used as High-Level Disinfectants or Chemical Sterilants
  • Table 3-3: Comparison of the Characteristics of Selected Hospital Disinfectants for General Disinfection of Environmental Surfaces
  • Table 3-4: New Developments, Hospital infection Prevention
  • Table 3-5: The Global Market for Hospital infection Prevention Equipment and Consumables 2010-2020
  • Figure 3-1: The Global Market for Hospital infection Prevention Equipment and Consumables 2010-2020
  • Figure 3-2: The Global Market for Hospital infection Prevention Equipment and Consumables Estimated Market Value by Use, (Medical Device/Instrument Sterilization, Wide-Area/Room Sterilization, Medical-grade Disinfection Solutions, Other Products)2010-2020
  • Figure 3-3: The Global Market for Hospital infection Prevention Equipment and Consumables Estimated Market Share by Department/Use, 2015
  • Figure 3-4: The Global Market for Hospital infection Prevention Equipment and Consumables Estimated Market Value by Technology, 2010-2020
  • Figure 3-6: The Global Market for Hospital infection Prevention Equipment and Consumables Estimated Market Share by Technology, 2015
  • Table 3-6: The Global Market for Hospital infection Prevention Estimated Products Sales by Primary Geographic Region 2010-2020
  • Figure 3-7: The Global Market for Hospital infection Prevention Estimated Product Sales by Primary Geographic Region 2010-2020
  • Figure 3-8: The World Market for Hospital infection Prevention Estimated Market Share by Region, 2015
  • Table 3-7: The Global Market for Hospital infection Prevention Leading Suppliers' Shares Estimates for 2015
  • Figure 3-9: The Global Market for Hospital infection Prevention Leading Suppliers' Shares Estimates for 2015

INFECTION TESTING

  • Table 4-1: Significant Approvals for Detecting Serious Hospital infections
  • Table 4-1 (continued): Significant Approvals for Detecting Serious Hospital infections
  • Table 4-1 (continued): Significant Approvals for Detecting Serious Hospital infections
  • Table 4-1 (continued): Significant Approvals for Detecting Serious Hospital infections
  • Figure 4-1: HAI Test Approvals* in the U.S. by Year and Type, 2000-2015
  • Table 4-2: New Developments, Hospital infection Testing
  • Table 4-3: The Global Market for Hospital infection Testing/Diagnostics 2010-2020
  • Figure 4-2: The Global Market for Hospital infection Testing/Diagnostics 2010-2020
  • Figure 4-3: The Global Market for Hospital infection Testing/Diagnostics Estimated Market Share by Test Indication, 2015
  • Table 4-4: The Global Market for Hospital infection Testing/Diagnostics Estimated Products Sales by Primary Geographic Region 2010-2020
  • Figure 4-4: The Global Market for Hospital infection Testing/Diagnostics Estimated Product Sales by Primary Geographic Region 2010-2020
  • Figure 4-5: The Global Market for Hospital infection Testing/Diagnostics Estimated Market Share by Region, 2015
  • Table 4-5: The Global Market for Hospital infection Testing/Diagnostics Leading Suppliers' Shares Estimates for 2015
  • Figure 4-6: The Global Market for Hospital infection Testing/Diagnostics Leading Suppliers' Shares Estimates for 2015

INFECTION TREATMENT

  • Table 5-1: Treatment Options for Bacterial Infections (Type, Brand, and Manufacturer)
  • Table 5-1 (continued): Treatment Options for Bacterial Infections (Type, Brand, and Manufacturer)
  • Table 5-1 (continued): Treatment Options for Bacterial Infections (Type, Brand, and Manufacturer)
  • Table 5-1 (continued): Treatment Options for Bacterial Infections (Type, Brand, and Manufacturer)
  • Table 5-1 (continued): Treatment Options for Bacterial Infections (Type, Brand, and Manufacturer)
  • Table 5-1 (continued): Treatment Options for Bacterial Infections (Type, Brand, and Manufacturer)
  • Table 5-1 (continued): Treatment Options for Bacterial Infections (Type, Brand, and Manufacturer)
  • Table 5-1 (continued): Treatment Options for Bacterial Infections (Type, Brand, and Manufacturer)
  • Table 5-1 (continued): Treatment Options for Bacterial Infections (Type, Brand, and Manufacturer)
  • Table 5-1 (continued): Treatment Options for Bacterial Infections (Type, Brand, and Manufacturer)
  • Table 5-1 (continued): Treatment Options for Bacterial Infections (Type, Brand, and Manufacturer)
  • Table 5-1 (continued): Treatment Options for Bacterial Infections (Type, Brand, and Manufacturer)
  • Table 5-1 (continued): Treatment Options for Bacterial Infections (Type, Brand, and Manufacturer)
  • Table 5-1 (continued): Treatment Options for Bacterial Infections (Type, Brand, and Manufacturer)
  • Table 5-2: Antibiotics with Difficult Penetration
  • Table 5-2 (continued): Antibiotics with Difficult Penetration
  • Table 5-3: Annual Sales of Select Antibacterial Products 2014
  • Table 5-4: New Developments, Hospital infection Treatments, as of December 2015
  • Table 5-4 (continued): New Developments, Hospital infection Treatments
  • Table 5-4 (continued): New Developments, Hospital infection Treatments
  • Table 5-5: The Global Market for Hospital infection Treatment 2010-2020
  • Figure 5-1: The Global Market for Hospital infection Treatment 2010-2020
  • Table 5-6: The Global Market for Hospital infection Treatment Estimated Products Sales by Primary Geographic Region 2010-2020
  • Figure 5-2: The Global Market for Hospital infection Treatment Estimated Product Sales by Primary Geographic Region 2010-2020
  • Figure 5-3: The Global Market for Hospital infection Treatment Estimated Market Share by Region, 2015
  • Table 5-7: The Global Market for Hospital infection Treatment Leading Suppliers' Shares Estimated Share for HAIs for 2015
  • Figure 5-4: The Global Market for Hospital infection Treatment Leading Suppliers' Shares Estimated Share for HAIs for 2015

MARKET OPPORTUNITIES FOR HOSPITAL INFECTION CONTROL

  • Table 6-1: The Global Market for Hospital infection Control 2010-2020
  • Figure 6-1: The Global Market for Hospital infection Control 2010-2020
  • Figure 6-2: The Global Market for Hospital infection Control Estimated Market Share by Segment, 2015
  • Figure 6-3: The Global Market for Hospital infection Control Estimated Market Share by Facility Setting, 2015
  • Figure 6-4: The Global Market for Hospital infection Control Estimated Market Share by Hospital Department, 2015
  • Table 6-2: The Global Market for Hospital infection Control Estimated Products Sales by Primary Geographic Region 2010-2020
  • Figure 6-5: The Global Market for Hospital infection Control Estimated Product Sales by Geographic Region 2010-2020
  • Figure 6-6: The Global Market for Hospital infection Control Estimated Market Share by Geographic Region, 2015
  • Table 6-3: Developed vs. Emerging Markets
  • Figure 6-7: The Global Market for Hospital infection Control Estimated Market Share by Region, 2015

COMPANY PROFILES

LIST OF MAJOR PROVIDERS

Back to Top